Bird B. AG
Venture capitalSchaffhausen · Seed–Growth · 1 people tracked
Investment thesis
BIRD B. AG invests in medical and technology companies focused on research, manufacturing, and distribution of advanced medical technology products. It backs leaders and inventors developing innovative ideas, products, and processes that durably improve the quality of life for people with medical conditions. The firm targets internationally operating companies with long-term perspectives, spanning startups to growth-stage businesses, and emphasizes solving significant unmet medical needs. Areas of interest include foot and ankle solutions, biomaterials, orthopedics, prosthetics, fracture fixation, surgical training, pediatric cardiovascular devices, and AI and robotics platforms that leverage large language models to support, coordinate, and partially or fully automate surgical workflows.
Source: firm website, verified Aug 7, 2026.
Team · 1 people
from public directoriesInvestments · 6 tracked
founders shown can be your intro pathFrequently asked questions
- What stage does Bird B. AG invest at?
- Bird B. AG invests at the Seed, Series A, Series B, Growth stages.
- What sectors does Bird B. AG focus on?
- Bird B. AG focuses on AI & Machine Learning, Biotech, Deep Tech, Healthtech, Medical Devices, New Materials, Robotics.
- Where is Bird B. AG located?
- Bird B. AG is headquartered in Schaffhausen, CH.
Similar investors
Taiwania Capital is a venture capital firm investing across technology and life science sectors, backing companies in Taiwan, Europe, and globally.
Quad Ventures is a Korean venture capital firm that identifies founders driving lifestyle and industry change and invests in the technologies enabling them, backing early-stage startups across advanced technology sectors.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.
Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.
Innovation Industries is a deep tech investor backing companies with ground-breaking technologies aimed at addressing fundamental global challenges, providing support to help them scale and maximize environmental, social, and economic impact.